Skinvisible (SKVI) Liabilities and Shareholders Equity (2010 - 2026)

Skinvisible has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $123334.0 for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity fell 13.98% year-over-year to $123334.0; the TTM figure through Jun 2026 stood at $503943.0 (down 15.98% YoY), while the FY2025 annual figure was $127567.0, down 19.37% from the prior year.
• Liabilities and Shareholders Equity came in at $123334.0 for Q2 2026 at Skinvisible, up from $119419.0 in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $320590.0 in Q2 2022 to a low of $119419.0 in Q1 2026.
• Average Liabilities and Shareholders Equity over 5 years is $177801.6, with a median of $160543.0 recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity soared 38.91% in 2022 and tumbled 38.76% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $246793.0 in 2022, then slumped by 34.01% to $162869.0 in 2023, then slipped by 2.86% to $158217.0 in 2024, then fell by 19.37% to $127567.0 in 2025, then retreated by 3.32% to $123334.0 in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $123334.0 in Q2 2026, $119419.0 in Q1 2026, and $127567.0 in Q4 2025.